MedTrace Logo

Neurostimulation to Treat Refractory Angina Pectoris Pain

NCT00200070 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2010-08-30

No results posted yet for this study

Summary

The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.

Conditions

  • Angina Pectoris

Interventions

DEVICE

Spinal Cord Stimulation

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Douglas Zipes · Indiana University School of Medicine

  • Nelson Svorkidal · Health Science Center, Winnipeg CANADA

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200070 on ClinicalTrials.gov